Henrik Bergentoft has decided to leave the position as CFO of RaySearch Laboratories AB (publ) for new challenges. Annika Blondeau Henriksson has been appointed interim CFO and she will also be part of the senior management team. Henrik will remain in a supporting role during his notice period.
Recruitment of a permanent CFO will begin immediately. Annika will remain as interim CFO until this person is in place.
Henrik Bergentoft: "I wish RaySearch good luck and success with its important mission in the fight against cancer. For me, an orderly handover to Annika remains."
Johan Löf, founder and CEO, RaySearch: "Henrik Bergentoft has done a good job during his short time at RaySearch and we wish him the best of luck in his continued career. With Annika Blondeau Henriksson assuming the role of interim CFO with immediate effect, we will have a competent professional ensuring our financial department’s capacity while the recruitment of a successor is underway.”
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00